Novo Nordisk A/S (BVMF:N1VO34)
Brazil · Delayed Price · Currency is BRL 33.52
+1.16 (3.58%)
At close: Nov 12, 2025
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.17 trillion as of November 13, 2025. Its market cap has decreased by -59.20% in one year.
Market Cap
1.17T
Enterprise Value
1.23T
Revenue
264.23B
Ranking
n/a
PE Ratio
13.50
Stock Price
33.52
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.50B to 1.17T, an increase of 15,541.22%. That is a compound annual growth rate of 19.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 1.17T | -51.23% |
| Dec 30, 2024 | 2.40T | 7.38% |
| Dec 29, 2023 | 2.24T | 39.16% |
| Dec 30, 2022 | 1.61T | 13.12% |
| Dec 30, 2021 | 1.42T | 68.94% |
| Dec 30, 2020 | 842.13B | 53.52% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.14B |
| Raia Drogasil | 37.89B |
| Hypera | 16.31B |
| Fleury | 8.62B |
| Odontoprev | 6.60B |
| Empreendimentos Pague Menos | 2.91B |
| Diagnósticos da América | 2.52B |
| Blau Farmacêutica | 2.21B |